Form 4: PureTech Health Disposes of Akili, Inc. Shares Following Merger

PureTech Health plc disposed of its Akili, Inc. shares at $0.4340 per share following the completion of a merger with Virtual Therapeutics Corporation on July 2, 2024.

Summary

• PureTech Health plc disposed of 12,527,477 shares of Akili, Inc. common stock.
• The transaction occurred on July 2, 2024, following the completion of a merger between Akili, Inc. and Virtual Therapeutics Corporation.
• The shares were disposed of at a price of $0.4340 per share, as per the merger agreement.
• PureTech Health LLC is the record holder of the securities, and PureTech Health plc has the power to direct the voting and disposition of these securities.
• The merger became effective on July 2, 2024, with Akili, Inc. surviving the merger.

Sentiment

Score: 6

Explanation: The sentiment is neutral as it reports a completed transaction (merger and subsequent share disposition). It doesn't inherently convey positive or negative implications for PureTech Health's future performance.

Future Outlook

The document does not contain any specific forward-looking statements regarding PureTech Health's future outlook beyond the completion of the merger and disposition of shares.

Industry Context

This announcement reflects a completed merger and acquisition activity within the biotechnology or healthcare technology sector, where Akili, Inc., a digital therapeutics company, was acquired by Virtual Therapeutics Corporation. Such mergers are common in the industry as companies seek to consolidate resources, technologies, and market presence.

Stakeholder Impact

• Shareholders of Akili, Inc. received $0.4340 per share as a result of the merger.
• PureTech Health disposed of its shares in Akili, Inc. as part of the merger agreement.

Key Dates